Plain-English translation of NCT06804642 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new approach called spinal cord transcutaneous stimulation — a non-invasive way to apply gentle electrical stimulation to your spine to help improve walking problems in Parkinson's disease. Unlike brain surgery approaches that are already available, this treatment does not require surgery and allows researchers to try different stimulation locations on your spine to find what works best for your gait. The goal is to help people with Parkinson's who have difficulty walking, especially problems that don't improve with current medications.
Many people with Parkinson's disease develop serious walking and balance problems that don't respond well to existing treatments, including standard medications and deep brain surgery. Researchers believe that stimulating the spinal cord might bypass these stubborn symptoms by working directly with the spine's natural ability to generate walking movements.
You likely qualify if…
You likely don't qualify if…
You would receive non-invasive electrical stimulation applied to your spine through electrode pads placed on your skin — no surgery required. The research team would test stimulation at different locations along your spine to map out which areas help your walking the most, and you would participate in activity-based training sessions. Throughout the study, you would be assessed on your gait and walking ability to see how the treatment affects your movement during daily activities.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States